A Quantitative Rabbit Model of Vaccinia Keratitis

被引：34

作者：

Altmann, Sharon ^{[2
]}

Emanuel, Andrew ^{[5
]}

Toomey, Megan

McIntyre, Kim ^{[4
]}

Covert, Jill ^{[4
,6
]}

Dubielzig, Richard Redd ^{[4
]}

Leatherberry, Gary ^{[4
]}

Murphy, Christopher J. ^{[3
,4
,6
,7
]}

Kodihalli, Shantha ^{[5
]}

Brandt, Curtis R. ^{[1
,2
,4
]}

机构：

[1] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA

[2] Univ Wisconsin, Dept Immunol & Med Microbiol, Madison, WI 53706 USA

[3] Univ Wisconsin, Dept Surg Sci, Madison, WI 53706 USA

[4] Univ Wisconsin, Comparat Ophthalm Res Labs, Madison, WI 53706 USA

[5] Canada Corp, Preclin Res, Winnipeg, MB, Canada

[6] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA

[7] Univ Calif Davis, Sch Med, Dept Ophthalmol & Visual Sci, Davis, CA 95616 USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 09期

基金：

美国国家卫生研究院;

关键词：

SMALLPOX VACCINATION; OCULAR COMPLICATIONS; EPIDEMIC OUTBREAK; VIRUS-INFECTION; TRANSMISSION; ANTIBODY; RESPONSES; IMMUNITY;

D O I：

10.1167/iovs.09-5106

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

PURPOSE. The goal of this study was to use multiple quantitative disease measures to evaluate the effect of various viral inocula on the development of vaccinia keratitis in rabbits. METHODS. Trephined eyes of female rabbits were infected with 10(4), 10(5), 10(6), or 10(7) plaque-forming units (pfu) of the Dryvax strain of the vaccinia virus and scored daily for disease for 14 days according to a modification of the MacDonald-Shadduck scoring system. Ocular viral titers and vaccinia-specific antibody titers were determined by plaque assay and ELISA, respectively. RESULTS. The amount of virus used for infection affected the severity of disease, with 10(4) pfu eliciting milder keratitis after delayed onset compared with higher amounts of virus. At inocula above 10(5) pfu the course and severity of corneal disease was not significantly different. The time to reach peak titers was delayed in the 10(4) group but peak titers were similar in all groups. Severe conjunctival chemosis interfered with scoring in animals infected with 10(6) or 10(7) pfu. Virus-specific antibody titers were similar in all groups at day 14. Body weights decreased less than 10% in all groups. CONCLUSIONS. The course of vaccinia keratitis in rabbits paralleled that in humans. A viral inoculum of 10(5) pfu/eye was determined to be optimal for use in further studies of vaccinia keratitis. (Invest Ophthalmol Vis Sci. 2010;51:4531-4540) DOI: 10.1167/iovs.09-5106

引用

页码：4531 / 4540

页数：10

共 39 条

[1] Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide [J].

Altmann, S. E. ;

Jones, J. C. ;

Schultz-Cherry, S. ;

Brandt, C. R. .

VIROLOGY, 2009, 388 (02) :248-259

[2]

[Anonymous], COMMUN DIS REP CDR W

[3]

Athanasiu P, 1984, Virologie, V35, P83

[4] Safety profile of smallpox vaccine: Insights from the laboratory worker smallpox vaccination program [J].

Baggs, J ;

Chen, RT ;

Damon, IK ;

Rotz, L ;

Allen, C ;

Fullerton, KE ;

Casey, C ;

Nordenberg, D ;

Mootrey, G .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (08) :1133-1140

[5]

Belongia Edward A, 2003, Clin Med Res, V1, P87

[6] Dose-dependent neutralizing-antibody responses to vaccinia [J].

Belshe, RB ;

Newman, FK ;

Frey, SE ;

Couch, RB ;

Treanor, JJ ;

Tacket, CO ;

Yan, LH .

JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (03) :493-497

[7] The role of viral and host genes in corneal infection with herpes simplex virus type 1 [J].

Brandt, CR .

EXPERIMENTAL EYE RESEARCH, 2005, 80 (05) :607-621

[8] THERAPEUTIC ACTION OF DISTAMYCIN A ON VACCINIA VIRUS INFECTIONS IN VIVO [J].

CASAZZA, AM ;

GHIONE, M .

CHEMOTHERAPY, 1964, 9 (02) :80-+

[9] Adverse events associated with smallpox vaccination in the United States, January-October 2003 [J].

Casey, CG ;

Iskander, JK ;

Roper, MH ;

Mast, EE ;

Wen, XJ ;

Török, TJ ;

Chapman, LE ;

Swerdlow, DL ;

Morgan, J ;

Heffelfinger, JD ;

Vitek, C ;

Reef, SE ;

Hasbrouck, LM ;

Damon, I ;

Neff, L ;

Vellozzi, C ;

McCauley, M ;

Strikas, RA ;

Mootrey, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (21) :2734-2743

[10]

*CDC, 2003, MMWR-MORBID MORTAL W, V52, P475

← 1 2 3 4 →